Transcriptomic Analysis Reveals Receptor Subclass–Specific Immune Regulation of CD8+ T Cells by Opioids
Author(s) -
Claire Mazahery,
Saba Valadkhan,
Alan D. Levine
Publication year - 2020
Publication title -
immunohorizons
Language(s) - English
Resource type - Journals
ISSN - 2573-7732
DOI - 10.4049/immunohorizons.2000019
Subject(s) - microbiology and biotechnology , t cell receptor , lipid raft , immune system , cd8 , cytotoxic t cell , signal transduction , receptor , biology , downregulation and upregulation , zap70 , t cell , chemistry , immunology , biochemistry , gene , in vitro
Opioid peptides are released at sites of injury, and their cognate G protein-coupled opioid receptors (OR) are expressed on immune cells. Exposure of human circulating CD8 + T cells to selective OR agonists differentially regulates thousands of genes. Gene set enrichment analysis reveals that μ-OR more strongly regulates cellular processes than δ-OR. In TCR naive T cells, triggering μ-OR exhibits stimulatory and inhibitory patterns, yet when administered prior to TCR cross-linking, a μ-OR agonist inhibits activation. μ-OR, but not δ-OR, signaling is linked to upregulation of lipid, cholesterol, and steroid hormone biosynthesis, suggesting lipid regulation is a mechanism for immune suppression. Lipid rafts are cholesterol-rich, liquid-ordered membrane domains that function as a nexus for the initiation of signal transduction from surface receptors, including TCR and μ-OR. We therefore propose that μ-OR-specific inhibition of TCR responses in human CD8 + T cells may be mediated through alterations in lipid metabolism and membrane structure.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom